CHRNA7 and neoplasm: Their efficacy on tumor growth inhibition in vivo was demonstrated on example of α-cobratoxin (Grozio et al., 2008), but such toxins inhibit α7-nAChR irreversibly and with high affinity, that may lead to high systemic toxicity in clinic.